tirzepatide molecule structure | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist β-Ala21]-Tirzepatide - Daicel Pharma Standards
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
![tirzepatide molecule structure | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist -Ala21]-Tirzepatide - Daicel Pharma Standards](https://www.daicelpharmastandards.com/wp-content/uploads/2024/02/dcti-d-323-1200x900.png)
![tirzepatide molecule structure | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist -Ala21]-Tirzepatide - Daicel Pharma Standards](https://media.sciencephoto.com/c0/59/27/23/c0592723-800px-wm.jpg)
![tirzepatide molecule structure | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist -Ala21]-Tirzepatide - Daicel Pharma Standards](https://www.sciencesource.com/pix/247/2476526-antidiabetic-drug-tirzepatide-molecular-structure.jpg)
![tirzepatide molecule structure | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist -Ala21]-Tirzepatide - Daicel Pharma Standards](https://www.daicelpharmastandards.com/wp-content/uploads/2025/04/dcti-d-557.png)








/assets/images/provider/photos/2636389.jpg)

/assets/images/provider/photos/2766296.jpeg)






